TL;DR
This study reveals that the epigenetic modification H3K4 methylation, mediated by the Set1 enzyme, is crucial for Candida glabrata's ability to induce ergosterol biosynthesis genes in response to azole antifungal drugs. Loss of Set1 leads to increased azole susceptibility, not by affecting drug efflux, but by impairing the induction of these essential genes, highlighting a novel epigenetic vulnerability in this opportunistic pathogen.
What Problem Does This Paper Address?
Candida glabrata is a significant opportunistic fungal pathogen that is notoriously difficult to treat due to its intrinsic resistance to azole antifungal drugs and its ability to develop multidrug resistance. While resistance mechanisms like drug efflux pump overexpression and target gene mutations are well-studied, the role of epigenetic modifications in azole resistance and gene regulation in C. glabrata has remained largely unexplored. This paper aims to bridge this knowledge gap by investigating the contribution of histone H3K4 methylation, a key epigenetic mark, to azole-induced gene expression and drug resistance in C. glabrata.
Methods
The researchers employed a multi-pronged approach to investigate the role of Set1 and H3K4 methylation:
- Yeast Genetics: They generated and utilized various Candida glabrata and Saccharomyces cerevisiae strains, including deletions of SET1 and its COMPASS complex subunits, as well as strains with mutations in histone H3.
- Phenotypic Assays: Serial dilution spot assays and liquid growth curves were used to assess azole drug susceptibility and growth phenotypes under drug treatment. Minimal Inhibitory Concentration (MIC) assays were also performed to quantify drug resistance.
- Molecular Biology Techniques:
- Western Blotting: Used to detect and quantify different levels of H3K4 methylation (mono-, di-, and trimethylation) in various mutant strains.
- Quantitative Real-Time PCR (qRT-PCR): Employed to measure the transcript levels of specific genes, including drug efflux pumps (CDR1, PDR1) and ergosterol biosynthesis genes (ERG genes).
- RNA-Sequencing (RNA-seq): Performed to conduct a genome-wide analysis of gene expression changes in set1Δ strains compared to wild-type under azole treatment.
- Chromatin Immunoprecipitation (ChIP): Used to determine the enrichment of H3K4 trimethylation on the chromatin of specific ERG genes.
- Nile Red Assay: A fluorescence-based assay to assess the functional activity of the Cdr1 drug efflux pump.
Datasets
The study utilized existing strains of Saccharomyces cerevisiae (e.g., BY4741) and Candida glabrata (e.g., ATCC 2001, ATCC 200989) obtained from standard collections. New strains were generated through genetic manipulation. RNA-seq data was generated by the authors and analyzed using standard bioinformatics pipelines (Trimmomatic, STAR, HTSeq, DESeq2).
Key Insights and Ideas
- H3K4 Methylation is a Conserved Regulator of Azole Resistance: The findings demonstrate that Set1-mediated H3K4 methylation plays a similar, critical role in azole drug resistance in both S. cerevisiae and C. glabrata. This suggests a conserved epigenetic mechanism across related fungal species.
- Resistance is NOT Due to Drug Efflux: A key finding is that the increased azole susceptibility in set1Δ strains is not caused by altered expression or function of major drug efflux pumps like Cdr1 or the transcription factor Pdr1. This shifts the focus away from a common resistance mechanism.
- Set1 Orchestrates Azole-Induced Gene Expression: The study pinpoints Set1's essential role in inducing the expression of genes involved in the ergosterol biosynthesis pathway, particularly ERG11 (the azole target) and ERG3, when C. glabrata is exposed to azoles.
- Epigenetic Mark on Target Genes: ChIP analysis directly shows that H3K4 trimethylation is enriched on the chromatin of ERG genes, and this enrichment increases upon azole treatment, directly linking the epigenetic mark to gene activation.
- Catalytic Activity is Essential: The study confirms that the catalytic activity of Set1's SET domain is crucial for H3K4 methylation and subsequent azole resistance, as a catalytically inactive mutant failed to rescue the set1Δ phenotype.
Key Results
- Deletion of SET1 in C. glabrata and S. cerevisiae leads to increased susceptibility to azole drugs like fluconazole.
- Loss of Set1 abolishes all forms of H3K4 methylation (mono-, di-, and trimethylation) in C. glabrata.
- Genome-wide RNA-seq analysis revealed that Set1 is required for the azole-induced expression of 12 genes in the late ergosterol biosynthesis pathway, including ERG11 and ERG3.
- ChIP analysis demonstrated that H3K4 trimethylation is enriched on the chromatin of ERG11 and ERG3 and increases upon azole treatment.
- A catalytically inactive mutant of Set1 (H1048K) failed to restore H3K4 methylation or azole resistance in set1Δ strains.
- Transcript levels of CDR1 and PDR1 were not significantly altered in set1Δ strains, and the Cdr1 efflux pump function remained intact.
Limitations and Future Work
- Mechanistic Details of COMPASS Subunits: While the study investigated several COMPASS complex subunits, the precise differential roles and assembly mechanisms of these subunits in C. glabrata (e.g., the distinct behavior of CgSpp1 compared to other subunits) warrant further investigation.
- Regulation of CDR1 and PDR1: Although not directly implicated in the set1Δ phenotype, the paper suggests that further investigation is needed to understand how CDR1 and PDR1 are epigenetically regulated in C. glabrata.
- Role in Virulence: The study primarily focuses on drug resistance. While it briefly speculates on the impact of Set1 loss on virulence in C. albicans and C. glabrata, a more direct investigation into the Set1-ERG pathway's role in fungal pathogenesis is a promising future direction.
- Broader Epigenetic Landscape: The paper highlights H3K4 methylation but acknowledges that other epigenetic factors (like histone deacetylases) are also involved in azole resistance, suggesting a complex interplay that could be explored further.
- Cross-Species Comparisons: While comparisons are made between S. cerevisiae and C. glabrata, understanding the precise reasons for differences in azole sensitivity and gene regulation (e.g., sterol uptake mechanisms) across different Candida species remains an area for future research.
Summary updated